Refine by
Therapeutic Development Services Near Romania
33 services found
by:Synthego based inMenlo Park,, CALIFORNIA (USA)
For CRISPR-based therapies, understanding the potential and actual off-target edits associated with your CRISPR drug components is critical to their safety and efficacy. Synthego has partnered with SeQure Dx, a leading off-target editing analysis company, to bring you best-in-class OTE analysis for your RUO-to-GMP gRNAs. Whether you are deciding among several gRNAs, characterizing your final ...
by:Click Therapeutics, Inc based inNew York, NEW YORK (USA)
Our therapeutics are developed in house by a team of doctorate-level translational and discovery scientists, working hand-in-hand with clinicians, patients and thought leaders in each therapeutic ...
Manufactured by:ACROBiosystems based inNewark, DELAWARE (USA)
Biomolecular interaction analysis is used increasingly in drug development to kinetically characterize binding events of relevant components, including drugs and targets, antibodies and antigens or any pair of interacting molecules. Based on the Biacore 8K and ForteBio Octet platforms, ACROBiosystems provides biopharmaceutical R&D customers with complementary molecular ...
by:UNITY Biotechnology based inSouth San Francisco, CALIFORNIA (USA)
We are developing therapeutics that target senescence and adjacent biology with broad application across multiple indications with established endpoints and well-defined regulatory pathways to approval. Our initial focus is on delivering localized therapy in ophthalmologic and neurologic ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
An important feature of antibody drugs is that they can be tailored making by genetic engineering and be prepared according to specific therapeutic needs. With the development of antibody genetic engineering technology, development of genetic engineered antibody as drug candidates is growing rapidly such as antibody-drug conjugates (ADC), ...
Manufactured by:Rocket Pharmaceuticals, Inc. based inCranbury, NEW JERSEY (USA)
Rocket’s Research and Discovery group in the Cranbury, New Jersey facility utilizes approximately 20,000 square feet of state-of-the-art laboratories for designing, optimizing and advancing candidate therapeutics to clinical stage ...
by:Cmbio based inCopenhagen, DENMARK
At Cmbio, we offer multi-omics solutions to explore the connections between the gut microbiome, digestion, and metabolism. Our tools provide actionable insights to drive research and therapeutic ...
by:Immunai based inNew York, NEW YORK (USA)
Comprehensively mapping the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient ...
by:Neuron Experts based inMarseille, FRANCE
To keep up its high level of Competitiveness, Neuron Experts constantly develops new cellular models to provide the most accurate answers to customers’ needs: Development of new neurodegenerative disease models following current discoveries of new therapeutic targets, Development of new cellular models to study interaction ...
Manufactured by:Veracyte, Inc. based inSouth San Francisco, CALIFORNIA (USA)
Veracyte offers customized biomarker testing and analytical services to our biopharmaceutical partners, helping them advance their therapeutic discovery, development and commercialization programs. We do this by leveraging our novel insights into the molecular underpinnings of disease and our extensive experience in drug development. Our ...
by:Wintermute Biomedical based inScoresby, AUSTRALIA
Wintermute launched the Doxall™ Sanitiser range in 2021 and has multiple other therapeutic formulations in its development pipeline. These including a Covid 19 preventative and treatment inhalant and a topical shingles therapeutic. Wintermute formulations demonstrate exceptional potential for the treatment of infections. ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Antibody characterization is important in research and biopharmaceutical development. All therapeutic proteins produced from current technologies have heterogeneities in the final product because various modifications occur during different stages of production. Due to these heterogeneities, thorough characterization is necessary for the reproducible and safe ...
Manufactured by:Veracyte based inMarseille Cedex 9, FRANCE
This analytics platform delivers valuable insights to improve patient care and help clinical researchers make informed decisions to advance therapeutic and diagnostic development. ...
Manufactured by:Kiadis Pharma NV based inAmsterdam, NETHERLANDS
New treatments for cancer that leverage our own immune system to attack and destroy cancer cells can provide long-term and durable therapeutic responses in patients suffering from life-threatening malignancies. These benefits for patients have been driven by recently developed therapeutic antibodies binding with high specificity to drug targets ...
by:Oncodesign based inDijon, FRANCE
It covers an extensive spectrum of pharmaceutical expertise and the ability to design and carry out precise and ad hoc assessments in the discovery and development of new therapies.Drawing on our experience and expertise in the preclinical investigation of new therapeutic entities – with different mechanisms of action – in various indications, and ...
by:Vertex Pharmaceuticals based inBoston, MASSACHUSETTS (USA)
Vertex is focused on discovering, developing and commercializing innovative medicines so people with serious diseases can lead better lives. Our scientists don’t see the impossible as an obstacle; they see it as a good place to start. These studies are investigating treatments or outcomes that have not all received approval from a health authority. The information presented is not intended ...
Manufactured by:SAGA Diagnostics AB based inLund, SWEDEN
Today, we know much about the many mutations which can contribute to cancer, some mutations which can be inherited, as well as the many gene mutations which arise randomly and due to environmental exposures. Increasingly, these mutations can be targeted by approved drugs as well as dozens of therapeutics currently in development around the ...
Manufactured by:Bio-Rad Laboratories, Inc. (Antibodies) based inHercules, CALIFORNIA (USA)
Reduce Lead Time for Antibody Generation: Assays supporting SARS-CoV-2 vaccine, therapeutic, and diagnostic test development must be robust, scalable, and transferable to laboratories worldwide. They need to be designed and validated rapidly, yet without compromising quality. We understand that critical antibody reagents for these vital assays must be highly ...
by:Biodesix based inBoulder, COLORADO (USA)
Working alongside our biopharmaceutical partners, we employ personalized and integrated approaches to uncover new solutions to diagnostic challenges with industry-leading expertise in blood-based ...
Manufactured by:Meda BioTech, Inc. based inWest Berlin, NEW JERSEY (USA)
Meda's Hybrid-Naiioeiigiiieeriiig™ drug delivery platform generates more commercial opportunities than we can pursue independently. Strategic partnering is thereforea critical component of our ability to advance Meda's novel therapeutics programs into clinical developmentand onto the ...